Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexgram Holdings Berhad is a Malaysian investment holding company that operates significantly in the healthcare sector through its subsidiary, Nexgram Biomedic. The company provides a range of medical services and products, including COVID-19 testing, vaccine distribution, and digital health solutions like the Tracesafe tracking system. Nexgram also focuses on medical device distribution and laboratory services to support public health initiatives in Southeast Asia. In addition to healthcare, the group has business interests in telecommunications, property development, and logistics. The company is listed on the ACE Market of Bursa Malaysia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexgram.